A randomized controlled trial of buprenorphine in the management of short-term ambulatory heroin withdrawal

Addiction

Volumn 97, Issue 11, 2002, Pages 1395-1404

  Lintzeris, Nicholas ^a,e   Bell, James ^b   Bammer, Gabriele ^c   Jolley, Damien J ^d   Rushworth, Louise ^a,f  

^a TURNING POINT ALCOHOL AND DRUG CENTRE   (Australia)

^b Langton Centre   (Australia)

^c The Australian National University   (Australia)

^d DEAKIN UNIVERSITY   (Australia)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f RECKITT BENCKISER   (United Kingdom)

Author keywords

Ambulatory; Buprenorphine; Clonidine; Detoxification; Heroin withdrawal; Randomized controlled trial

Indexed keywords

ALCOHOL; AMPHETAMINE; BUPRENORPHINE; CANNABIS; CLONIDINE; COCAINE; DIAMORPHINE; DIAZEPAM; IBUPROFEN; METHADONE; METOCLOPRAMIDE; NALTREXONE; PSYCHEDELIC AGENT; QUININE SULFATE; SCOPOLAMINE BUTYL BROMIDE; TEMAZEPAM;

ADULT; AGITATION; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DETOXIFICATION; DISEASE SEVERITY; DROWSINESS; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; DYSPHORIA; FATIGUE; FEMALE; HEADACHE; HEROIN DEPENDENCE; HUMAN; HYPOTENSION; LETHARGY; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; NAUSEA; OUTPATIENT; PARESTHESIA; PATIENT COUNSELING; RANDOMIZED CONTROLLED TRIAL; REBOUND; SENSORY DYSFUNCTION; SLEEP DISORDER; SWEATING; TREATMENT OUTCOME; VERTIGO; VOMITING; WITHDRAWAL SYNDROME; XEROSTOMIA;

ADULT; AMBULATORY CARE; BUPRENORPHINE; CLONIDINE; FEMALE; HEROIN DEPENDENCE; HUMANS; MALE; NARCOTICS; PATIENT COMPLIANCE; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE WITHDRAWAL SYNDROME; SYMPATHOLYTICS;

EID: 0036845292     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1360-0443.2002.00215.x     Document Type: Article

References (27)

1. Barnett, P. G., Rodgers, J. H. & Bloch. D. A. (2001) A meta-analysis comparing bulprenorphine to methadone for treatment of opiate dependence. Addiction, 96, 683-690.
2. Bickel, W. K. & Amass, L. (1995) Buprenorphine treatment of opioid dependence: A review. Experimental and Clinical Psychopharmacology, 3, 477-489.
3. Bickel, W. K., Stitzer, M. L., Bigelow, G. E., Liebson, I. A., Jasinski, D. R. & Johnson, R. E. (1988) A clinical trial of buprenorphine: Comparison with methadone in the detoxification of heroin addicts. Clinical Pharmacology and Therapeutics. 43: 72-78.
4. Cheskin, L. J., Fudala, P. J., Johnson, R. E. (1994) A controlled comparison of buprenerphine and clonidine for acute detoxification from opioids. Drug and Alcohol Dependence, 36, 115-121.
5. Darke, S. (1998) Self-report among injecting drug users: A review. Drug and Alcohol Dependence, 51, 253-263.
6. Darke, S., Heather, N., Hall, W., Ward, J. & Wodak, A. (1991) Estimating drug consumption in opioid users: Reliability and validity of a 'recent use' episodes method. British Journal of Addiction, 86, 1311-1316.
7. Gossop, M. (1988) Clonidine and the treatment of the opiate withdrawal syndrome. Drug and Alcohol Dependence, 21, 253-259.
8. Gowing, L., Ali, R., White, J. (2000) Buprenorphine for the management of opioid withdrawal. Cochrane Database, 3, 1469-1493.
9. Gowing, L., Ali, R., White, J. (2000b) The management of opioid withdrawal: An overview of the research literature. In: Drug and Alcohol Services Council Research Series Monograph no. 9. Adelaide: Drug and Alcohol Services Council.
10. Handelsman, L., Cochrane, K. J., Aronson, M. J., Ness, R., Rubinstein, K. J. & Kanof, P. D. (1987) Two new rating scales for opiate withdrawal. American Journal of Drug and Alcohol Abuse, 13, 293-308.
11. Jasinski, D. R., Pevnick, J. S., Griffith, J. D. (1978) Human pharmacology and abuse potential of the analgesic buprenorphine: A potential agent for treating narcotic addiction. Archives General Psychiatry, 35, 501-516.
12. Johnson, R. E., Cone, E. J., Henningfield, J. E. & Fudula, P. J. (1989) Use of buprenorphine in the treatment of opiate addiction. I. Physiologic and behavioral effects during a rapid dose induction. Clinical Pharmacology and Therapeutics, 46, 335-343.
13. Kosten, T. R. & Kleber, H. D. (1988) Buprenorphine detoxification from opioid dependence: A pilot study. Life Science, 42, 635-641.
14. Ling. W., Charuvastra, C., Collins, J., Batki, S., Brown, L. S., Kintaudi, P. & Wesson, D. (1998) Buprenorphine maintenance treatment of opiate dependence: A multicenter, randomized clinical trial. Addiction, 93, 475-486.
15. Lintzeris, N. (2002) Buprenorphine dosing regimes in the management of out-patient heroin withdrawal. Drug and Alcohol Review, 21, 39-45.
16. Lintzeris, N., Clark, N. C., Muhleisen, P., Ritter, A., Ali, B., Bell, J., Hawkin, L., Monheit, B. & White. J. (2001) National Clinical Guidelines on the Use of Buprenorphine in the Management of Heroin Dependence. Canberra: National Drug Strategy, Commonwealth of Australia.
17. Mattick, R. P. & W. Hall. (1996) Are detoxification programmes effective? Lancet, 347, 97-100.
18. Nath, R. P., Upton, R. A., Everhart, E. J., Cheung, P., Schwonek, P., Jones, R. T. & Mendelson, J. E. (1999) Buprenorphine pharmacokinetics: Relative bioavailability of sublingual tablet and liquid formulations. Journal of Clinical Pharmacology, 39, 619-623.
19. Nigam, A. K., Ray, R., Tripathi, B. M. (1993) Buprenorphine in opiate withdrawal: A comparison with clonidine. Journal of Substance Abuse Treatment, 10, 391-394.
20. O'Connor, P., Carrol, K. M., Shi, J. M., Schottenfeld, R. S. & Kosten, T. R. (1997) Three methods of opioid detoxification in a primary care setting. A randomized trial. Annals Internal Medicine, 127, 526-530.
21. Schneider, U., Paetzold, W., Eronat, V., Huber, T. J., Seifert, J., Wiese, B. & Emrich, H. M. (2000) Buprenorphine and carbamazepine as a treatment for detoxification of opiate addicts with multiple drug misuse: A pilot study. Addiction Biology. 5, 65-69.
22. Schuh, K. J. & Johanson. C. E. (1999) Pharmacokinetic comparison of the buprenorphine sublingual liquid and tablet. Drug and Alcohol Dependence, 56, 55-60.
23. Signorini, D., Leung, O., Simes, R. J., Beller, E., Gebski, V. J. & Callaghan, T. (1993) Dynamic balanced randomisation for clinical trials. Statistics in Medicine, 12, 2343-2350.
24. Tucker, T. & Ritter, A. (2000) Naltrexone in the treatment of heroin dependence: A literature review. Drug and Alcohol Review, 19, 73-82.
25. Umbricht, A., Montoya, I. D., Hoover, D. R., Demuth, K. L., Chiang, C. T. & Preston, K. L. (1999) Naltrexone shortened opioid detoxification with buprenorphine. Drug and Alcohol Dependence, 56, 181-190.
26. Vignau, J. (1998) Preliminary assessment of a 10-day rapid detoxification programme using high dosage buprenorphine. European Addiction Research, 4, 29-31.
27. West. S. L., O'Neal, K. K. & Graham, C. W. (2000) A meta-analysis comparing the effectiveness of buprenorphine and methadone. Journal of Substance Abuse Treatment, 12, 405-414.